LENSAR, Inc. LNSR

Company Overview

LENSAR, Inc. is a U.S.-based medical technology company focused on advanced laser systems and imaging technologies for ophthalmic surgery, primarily cataract procedures. The company operates within the ophthalmology and surgical device industries and develops platforms intended to improve precision, imaging, and workflow efficiency during refractive cataract surgery. Its core commercial offering is the LENSAR Laser System, which integrates femtosecond laser technology with proprietary imaging and artificial intelligence-enabled planning tools designed to support surgeons during lens fragmentation, capsulotomy, and corneal incisions.

The company’s principal revenue drivers include sales and placements of laser systems, recurring procedure-based revenues, service agreements, and consumable products associated with its installed base. LENSAR primarily serves ophthalmic surgeons, ambulatory surgery centers, and hospitals performing cataract surgery procedures, with a strategic emphasis on premium cataract and refractive procedures. Founded in 2004, the company evolved from a development-stage ophthalmic laser business into a publicly traded medical device company listed on Nasdaq under the ticker LNSR. Its market positioning is centered on combining imaging, surgical automation, and AI-based planning capabilities within a specialized cataract surgery platform.